# OnCo record nct04829604 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04829604/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04829604", "NCT04829604" ;
  schema:name "ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)"@en ;
  schema:alternateName "ACE-Breast-03"@en ;
  schema:description "A phase 2 trial of ARX788 in HER2-positive breast cancer, run by Ambrx, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04829604/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04829604> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2021-10-26" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/site-specific-conjugation/> ;
  onco:drugs <https://onco.cc/drugs/arx788/> ;
  onco:companies <https://onco.cc/companies/ambrx/> .